What is the role of digoxin in dogs with atrial fibrillation and what is a major monitoring consideration?

• A. Improves rate control and contractility; monitor electrolytes and potential toxicity
• B. Improves rate control only; monitor kidney function
• C. Improves contractility only; monitor liver enzymes
• D. No effect on rate; monitor electrolytes

Answer: (A)

Digoxin helps in atrial fibrillation by two main actions: it increases the strength of heart muscle contractions (positive inotropy) and it slows conduction through the atrioventricular (AV) node (negative chronotropy). Slowing AV nodal conduction lowers the ventricular rate, which improves cardiac filling and overall perfusion during AF. At the same time, the positive inotropic effect can boost cardiac output in dogs with concurrent heart disease, so it serves both rate control and improved contractility.

The major monitoring consideration is the risk of toxicity, given digoxin’s narrow therapeutic window and renal clearance. Electrolyte balance is critical because disturbances, especially potassium, calcium, and magnesium levels, can heighten toxicity or alter the drug’s effect. Regular monitoring for signs of toxicity and, when possible, checking serum digoxin concentration and renal function helps ensure safe, effective use.